{"id":"https://openalex.org/W4361961032","doi":"https://doi.org/10.1158/1078-0432.c.6517917","title":"Data from CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo","display_name":"Data from CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361961032","doi":"https://doi.org/10.1158/1078-0432.c.6517917"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6517917","doi":"https://doi.org/10.1158/1078-0432.c.6517917","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6517917","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6517917","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114045976","display_name":"Archie N. Tse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Archie N. Tse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020814446","display_name":"Katherine G. Rendahl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine G. Rendahl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041344060","display_name":"Tahir N. Sheikh","orcid":"https://orcid.org/0000-0002-9410-1712","observed_orcids":["https://orcid.org/0000-0002-9410-1712"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tahir Sheikh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058570895","display_name":"Haider Cheema","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haider Cheema","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042650210","display_name":"Kim Aardalen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Aardalen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003346545","display_name":"Millicent G. Embry","orcid":"https://orcid.org/0009-0007-2143-6179","observed_orcids":["https://orcid.org/0009-0007-2143-6179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Millicent Embry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049526884","display_name":"Sylvia Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvia Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059376103","display_name":"Edward J. Moler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward J. Moler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069030673","display_name":"Zhi Jie Ni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhi Jie Ni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110129875","display_name":"Daniel E. Lopes de Menezes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel E. Lopes de Menezes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084402708","display_name":"Barbara Hibner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Hibner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002644188","display_name":"Thomas G. Gesner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas G. Gesner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.04039999842643738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.028200000524520874,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chk1-inhibitor","display_name":"CHK1 inhibitor","score":0.9160000085830688},{"id":"https://openalex.org/keywords/topoisomerase-i-poisons","display_name":"topoisomerase I poisons","score":0.9819999933242798},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.8880000114440918},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9769999980926514},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9810000061988831},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5740000009536743},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.7900000214576721},{"id":"https://openalex.org/keywords/intra-s-phase-checkpoint","display_name":"S-phase checkpoint","score":0.9570000171661377},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cdc25a","display_name":"CDC25A","score":0.925000011920929},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/quinolones","display_name":"quinolones","score":0.6819999814033508},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.593999981880188},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.6437129974365234},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6075116991996765},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.573625922203064},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5304681062698364},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.506438136100769},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.4993729591369629},{"id":"https://openalex.org/C50001416","wikidata":"https://www.wikidata.org/wiki/Q17861750","display_name":"CHEK1","level":5,"score":0.49372968077659607},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4802256226539612},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.44219258427619934},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4357983469963074},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.43093788623809814},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4169100224971771},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33507418632507324},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22655460238456726},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.18228086829185486}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6517917","doi":"https://doi.org/10.1158/1078-0432.c.6517917","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6517917","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6517917","doi":"https://doi.org/10.1158/1078-0432.c.6517917","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6517917","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076324577","https://openalex.org/W1997331071","https://openalex.org/W2045436471","https://openalex.org/W2106622937","https://openalex.org/W2035834282","https://openalex.org/W3188421389","https://openalex.org/W2047383934","https://openalex.org/W2165632524","https://openalex.org/W2141306016","https://openalex.org/W1978408731"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Chk1":[2,36,95,185,193,234],"kinase":[3],"is":[4,75,81,181,195,229],"a":[5,34,76,230],"critical":[6],"regulator":[7],"of":[8,33,88,149,155,164,177,200,216],"both":[9],"S":[10,135],"and":[11,30,55,70,92,136,139,153,223,232],"G2-M":[12,137,151,221],"phase":[13],"cell":[14,49,68,121],"cycle":[15,50],"checkpoints":[16,138],"in":[17,65,96,112,116,142,197,203,242],"response":[18,128],"to":[19,25,47,52,56,84],"DNA":[20,189],"damage.":[21],"This":[22],"study":[23],"aimed":[24],"evaluate":[26],"the":[27,133,150,162,175,198,212,220],"biochemical,":[28],"cellular,":[29],"antitumor":[31,238],"effects":[32,215],"novel":[35,231],"inhibitor,":[37],"CHIR124.":[38],"Experimental":[39],"Design:":[40],"CHIR-124":[41,74,102,131,158,171,210,228],"was":[42],"evaluated":[43],"for":[44,186],"its":[45],"ability":[46],"abrogate":[48],"checkpoints,":[51],"potentiate":[53],"cytotoxicity,":[54],"inhibit":[57],"Chk1-mediated":[58],"signaling":[59,194],"induced":[60],"by":[61,125,157,161,184,218],"topoisomerase":[62,106,245],"I":[63,246],"poisons":[64,107],"human":[66],"tumor":[67,120,225],"line":[69],"xenograft":[71,208],"models.":[72],"Results:":[73],"quinolone-based":[77],"small":[78],"molecule":[79],"that":[80,170,192],"structurally":[82],"unrelated":[83],"other":[85],"known":[86],"inhibitors":[87],"Chk1.":[89],"It":[90],"potently":[91],"selectively":[93],"inhibits":[94],"vitro":[97],"(IC50":[98],"=":[99],"0.0003":[100],"\u03bcmol/L).":[101],"interacts":[103],"synergistically":[104],"with":[105,236,244],"(e.g.,":[108],"camptothecin":[109],"or":[110,127],"SN-38)":[111],"causing":[113],"growth":[114,213],"inhibition":[115],"several":[117],"p53-mutant":[118],"solid":[119],"lines":[122],"as":[123],"determined":[124],"isobologram":[126],"surface":[129],"analysis.":[130],"abrogates":[132],"SN-38\u2013induced":[134],"potentiates":[140,211],"apoptosis":[141,156],"MDA-MD-435":[143],"breast":[144,206],"cancer":[145,207],"cells.":[146],"The":[147],"abrogation":[148],"checkpoint":[152,222],"induction":[154],"are":[159],"enhanced":[160],"loss":[163],"p53.":[165],"We":[166],"have":[167],"also":[168],"shown":[169],"treatment":[172],"can":[173],"restore":[174],"level":[176],"cdc25A":[178],"protein,":[179],"which":[180],"normally":[182],"targeted":[183],"degradation":[187],"following":[188],"damage,":[190],"indicating":[191],"suppressed":[196],"presence":[199],"CHIR-124.":[201],"Finally,":[202],"an":[204],"orthotopic":[205],"model,":[209],"inhibitory":[214],"irinotecan":[217],"abrogating":[219],"increasing":[224],"apoptosis.":[226],"Conclusions:":[227],"potent":[233],"inhibitor":[235],"promising":[237],"activities":[239],"when":[240],"used":[241],"combination":[243],"poisons.":[247]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}